These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22838063)

  • 1. Multilayer film applications in drug delivery: what's new and where to next?
    Haynie DT
    Ther Deliv; 2012 Jun; 3(6):671-3. PubMed ID: 22838063
    [No Abstract]   [Full Text] [Related]  

  • 2. Challenges of therapeutic delivery using conducting polymers.
    Poole-Warren L; Goding J
    Ther Deliv; 2012 Apr; 3(4):421-7. PubMed ID: 22834074
    [No Abstract]   [Full Text] [Related]  

  • 3. Nanocarriers.
    Torchilin VP
    Pharm Res; 2007 Dec; 24(12):2333-4. PubMed ID: 17934800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buccal drug delivery: what's new and what does the future hold?
    Giannola LI; De Caro V; Sutera FM
    Ther Deliv; 2014; 5(9):965-8. PubMed ID: 25375339
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting our snacking culture to improve patient compliance.
    Shahiwala A
    Ther Deliv; 2012 May; 3(5):579-81. PubMed ID: 22834402
    [No Abstract]   [Full Text] [Related]  

  • 6. Nasal-to-CNS drug delivery: where are we now and where are we heading? An industrial perspective.
    Landis MS; Boyden T; Pegg S
    Ther Deliv; 2012 Feb; 3(2):195-208. PubMed ID: 22834197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrospun nanofibers in drug delivery: recent developments and perspectives.
    Williams GR; Chatterton NP; Nazir T; Yu DG; Zhu LM; Branford-White CJ
    Ther Deliv; 2012 Apr; 3(4):515-33. PubMed ID: 22834080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptides for specific intracellular delivery and targeting of nanoparticles: implications for developing nanoparticle-mediated drug delivery.
    Delehanty JB; Boeneman K; Bradburne CE; Robertson K; Bongard JE; Medintz IL
    Ther Deliv; 2010 Sep; 1(3):411-33. PubMed ID: 22816144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Location, location, location: gastrointestinal delivery site and its impact on absorption.
    Connor A
    Ther Deliv; 2012 May; 3(5):575-8. PubMed ID: 22834401
    [No Abstract]   [Full Text] [Related]  

  • 10. Nanospray Drying Technology: Existing Limitations and Future Challenges.
    Wui WT
    Recent Pat Drug Deliv Formul; 2015; 9(3):185-6. PubMed ID: 25966873
    [No Abstract]   [Full Text] [Related]  

  • 11. The 12th Conference on the Formulation and Delivery of Bioactives.
    Tucker IG
    Ther Deliv; 2010 Jul; 1(1):25-7. PubMed ID: 22816116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlling subcellular delivery to optimize therapeutic effect.
    Mossalam M; Dixon AS; Lim CS
    Ther Deliv; 2010 Jul; 1(1):169-93. PubMed ID: 21113240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of drug product development.
    Narayan P
    Curr Protoc Pharmacol; 2011 Dec; Chapter 7():Unit 7.3.1-29. PubMed ID: 22147349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical considerations in development of solid dosage forms that contain cyclodextrin.
    Miller LA; Carrier RL; Ahmed I
    J Pharm Sci; 2007 Jul; 96(7):1691-707. PubMed ID: 17243148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decades of research in drug targeting to the upper gastrointestinal tract using gastroretention technologies: where do we stand?
    Awasthi R; Kulkarni GT
    Drug Deliv; 2016; 23(2):378-94. PubMed ID: 25026414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applicability, Commercial Utility and Recent Patents on Starch and Starch Derivative as Pharmaceutical Drug Delivery Carrier.
    Pandey S; Malviya R; Sharma PK
    Recent Pat Drug Deliv Formul; 2015; 9(3):249-56. PubMed ID: 26205680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confectionery-based dose forms.
    Tangso KJ; Ho QP; Boyd BJ
    Curr Drug Deliv; 2015; 12(1):56-62. PubMed ID: 25146440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interdependence of Dosage Form Microstructure and Performance.
    Axel Zeitler J; Rades T
    Pharm Res; 2017 May; 34(5):887-889. PubMed ID: 28299534
    [No Abstract]   [Full Text] [Related]  

  • 19. Hydrogels as drug-delivery platforms: physicochemical barriers and solutions.
    Alkayyali LB; Abu-Diak OA; Andrews GP; Jones DS
    Ther Deliv; 2012 Jun; 3(6):775-86. PubMed ID: 22838072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Formulation and special investigations of innovative intraoral solid dosage forms.].
    Kristo K; kATONA B; Piukovics P; Olah I; Sipos B; Sipos SE; Sovany T; Hodi K; Ifi Regdon G
    Acta Pharm Hung; 2016; 86(3):99-111. PubMed ID: 29489081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.